This just in from the Centers for Medicare & Medicaid Services:
“At the request of the laboratory’s director, Theranos was granted an extension until February 12 to submit their response to the CMS inspection report. This is a routine procedure in oversight of clinical labs.”
A CMS inspection of Theranos’ lab in Read More …
Source:: Future of You
